L. Palomera et al., Fatal myelofibrosis following fludarabine administration in a patient withindolent lymphoma, HAEMATOLOG, 83(11), 1998, pp. 1045-1046
We report a case of fulminant myelofibrosis after administration of fludara
bine in a patient diagnosed as having refractory low-grade lymphoma, progre
ssing fatally. Myelofibrosis in the setting of an indolent lymphoma is very
rare; this fact, and the short period between drug administration and fibr
osis suggest an etiopathogenic link, although this potential and severe adv
erse effect of fludarabine has not been previously reported in the literatu
re.